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The College of Veterinary Medicine Center of Excellence has just concluded its twelfth year of 
existence and its seventh year as an accomplished center. The benchmarks set at the inception of 
this Center have been exceeded every year. For instance, this year the average number of peer 
reviewed publications per member is over seven, indeed a remarkable achievement. 
Despite recent level funding the center is growing and our faculty are achieving great success in 
the very competitive area offederallnational support. One of the greatest achievements, largely 
due to the center, is th~ award of an NIH Training Grant. This grant is a collaborative effort 
between the College of Veterinary Medicine, Department of Pathology and the Biology Division 
of the Oak Ridge National Laboratories and is to train outstanding researchers in the area of 
molecular pathobiology of environmental diseases. The proposal was for $700,000 over a five 
year period. 
This year, we were not only reviewed by our external review committee, which review occurs 
every few years, but we also had the pleasure of a review on behalf of the Tennessee Higher 
Education Commission (THEC) which stated in its written review that: 
"The Center has been very successful in attracting external funding. Over the past 

five years, over $19 million has been awarded to the Center to support these 

research projects. While the College of Veterinary Medicine is among the smallest 

in the nation, it ranks fourth in external research funding." 

The external reviewers' writlcn report stated: 
"In conclusion, we congratulate the Dean and the faculty on the fine 

accomplishments of the Center...continues to be an important asset to the 

University and the State." 

We will continue to refine our Center to best match areas of the most impact on Tennesseans. 
Currently, the researchers of the Center cover a wide spectrum of areas- bovine mastitis, human 
and animal reproduction, infectiolls diseasl:s, vaccines, animal models for important human 
diseases such a polycystic kidney disease, cancer, and host defensive mechanisms important in 
immune mediated diseases. 
This Center of Excellence continues to be a wonderful investment with returns of almost $2.5 
million per yar of external funding on a state investment of roughly $500,00 (5 :1). Would that 
we could all invest so well. 
----------
August 2, 1996 
Page two 
The forging of links and partnerships with other recognized institutions such as Oak Ridge 
National Laboratories has enabled collaborative proposals to be submitted for funding from 
external agencies that heretofore we were unable to access. These relationships should broaden 
our expertise, especially in the molecular biologyltransgenic mouse areas. 
One note of caution is that our state support has been level for a number of years while costs 
have risen exponentially. We are very thankful for the support but with the increased price of 
everything from per diem for mice to rapidly increasing spare parts for an aging electron 
microscope, the Center really does need a raise. The College of Veterinary Medicine is a major 
success story which shows the Tennessee taxpayers how well their money is being invested in 
their, and Tennessee's, future. 
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Center of Excellence 

Program Report (1995-96) 

The Center of Excellence has been in existence for over eleven years. Although external 
funding levels have reached a plateau over the last five to six years (approximately $2.3 
million/year), the Center continues to grow in terms of its benchmarks. The Center of Excellence 
can be proud, in particular, of the number of peer-reviewed articles published by participants in 
1995-96 (153 total, a mean of 7.29 per member). It is a tribute to our members that they have 
been able to maintain funding levels in spite of a very unfavorable funding climate. 
The Center experienced considerable scrutiny this past year. First as part of the Tennessee 
Higher Education Committee five-year review and second by the external scientific review team 
(chaired by Dr. Peter Eyre, Dean, Virginia-Maryland Regional College of Veterinary Medicine). I 
am pleased to report that the Center received excellent reviews (see Appendix) and support the 
direction in which the Center is evolving. As suggested by the external review team, we will 
continue to seek an external scientific review every three years. 
The essence and direction of the COE is determined by the key participants 10 the 
program. And, like any good program, the Center must be flexible to accommodate changes in 
personnel and yet maintain its overall goals. We are likely to have several new participants in the 
next year or two as a result of recruiting for research positions vacated because of retirement and 
resignation. This infusion of new researchers into the Center can only further stimulate the vitality 
of our research program. However, we realize also that subtle differences in research emphasis 
may also be a consequence of filling these positions. Furthermore, changes in personnel and the 
nature of external funding over the last year has provided also an opportunity for reviewing 
current COE research focus areas (Inflammation and Host Defenses, Growth Factors and 
Molecular Genetics, Infectious Diseases and Population Medicine, In Vitro Toxicology and 
Toxicokinetics, and Carcinogenesis and Developmental Therapeutics). 
Two personnel changes occurred during the year. Dr. Ted McDonald, Professor, 
Department of Animal Science retired from the University of Tennessee after 41 years of service 
and Dr. Mark Miller joined the staff at Bowman Gray School of Medicine at Wake Forest 
University in Winston-Salem, North Carolina. 
Strategic Plan 
After Dr. Potgieter took on the responsibility as Director of Research and Graduate 
programs (including direct administration of the COE), it was proposed that the Dean eliminate all 
standing research and COE advisory committees and replace them with a single committee to 
advise the college on all research and graduate issues. It was envisaged that this committee would 
have a critical role in the research and graduate training policies of the college and also be 
responsible for reviewing all internal funding proposals for research or research equipment. 
Although the mechanism by which this committee functions is still evolving, it has been very 
active since its inception, is fulfilling its objectives, and its influence is growing. 
As a consequence, the definition, policies and procedures of the COE and the description 
of the research focus areas have been targets of ongoing discussion. Mechanisms to promote 
greater participation and/or communication were explored . 
One goal of the Center that should receive greater attention is to identify faculty with 
research potential and provide appropriate venture opportunities. Therefore, this goal was placed 
as one of the four priorities for funding by the Center. Also, the notion that specific faculty were 
"invited to be members" of the Center is to be discontinued. It was decided to solicit proposals 
from all eligible faculty (those with "significant" research appointments) and all who then receive 
funding from COE would be listed as "Faculty Funded for the Fiscal Year." Of course, only 
proposals that met the broad objectives of the Center would be considered. 
Now all the projects supported by COE (supporting or venture) are folded into a single 
competition; all researchers funded will be listed as "Faculty Funded for 199X - 199X" in future 
COE reports. Also, the COE will continue to fund a modest number of summer stipends for 
veterinary students to promote careers in research. 
The Center of Excellence will continue to fund equipment purchases; requests will be 
solicited from COE-funded researchers and recommendations for purchase by the Research and 
Graduate Programs Advisory Committee will be made to the Dean and Executive Committee. 
An argument was made in the five-year report that there is considerable merit in modifying 
research focus areas within the Center. These arguments are valid, but in defining areas of focus, 
we should also reflect our areas of strength within the Center. Some researchers have shifted 
emphasis of their research on human disease slightly from exclusive use of animal models to 
include also in vitro systems. This shift should be reflected in descriptions of the goals and areas 
of research focus . We proposed, therefore, to use the term animal/laboratory model whenever 
animal model has been used in the past. This then will more accurately reflect what several 
researchers are doing than the current terminology. 
We proposed also to not only change the areas of research focus from the five that have 
been operative in the immediate past to reflect the disciplines involved, but also to indicate the 
connection with the mission of the Center. The new groups are: 
Mission 1: Livestock Diseases ­
Focus Groups: 
Infectious DiseasesfPopulation Medicine 
Toxicoses 
Reproduction 





This terminology reflects the relationship of our research to the mission of the Center, the 
nature of the disciplines involved, and also the strengths of our researchers. Furthermore, an 
established researcher is available to be assigned, based on their funded programs, to each of these 
sections to serve as coordinators/leaders. 
The coordinators for the six research focus groups are as follows: 
Infectious DiseasesfPopulation Medicine: David Brian 
Toxicoses: Terry Schultz 
Reproduction: Linda Munson 
Host Defense: David Slauson 
Molecular Genetics: Erby Wilkinson 
Carcinogenesis: Hildegard Schuller 
The charge to the coordinators is to identify participants in each field, promote the 
formation of research alliances among potential participants (particularly between applied and 
basic disciplines), summarize and present research progress by faculty funded by COE 
periodically, and promote dissemination of research activity of the Center. 
Major Research Activity in the Center of Excellence 
Goal 1­
To Improve the Quality of Human Life Through Better Animal Health 
Several investigators contributed to this goal. Dr. Stephen Oliver worked on bovine 
mastitis to help ensure a safer food product. He has developed a highly accurate and specific 
method for identification of Streptococcus bacteria in milk. 
Endometriosis affects one of every seven women in the United States, resulting in pain and 
infertility. In this disease, the cells that normally line the uterus grow inside the abdominal cavity, 
causing organs to adhere together and become constricted and dysfunctional. 
Dr. Linda Munson's goal has been the development of a model for endometriosis in 
order to test factors that worsen this condition. She has developed a mouse model in which 
human uterine lining cells are transplanted into the abdominal cavity. This model will be used to 
develop new therapies for endometriosis. 
Dr. Kevin Hahn and co-workers have conducted clinical and laboratory research trials on 
client-owned pet animals with naturally-occurring cancer to identify new methods for the 
diagnosis and treatment of human beings with cancer. Results from these trials have led to new 
concepts in how anticancer drugs should be given to increase the potential for tumor control 
( cure) and decrease the likelihood of side effects, especially in smaller-sized patients (pediatric 
patients). 
Dr. David Brian's laboratory investigated coronaviruses that infect many speCIes, 
including cattle. By studying the molecular biology of bovine coronavirus replication, Dr. Brian 
has identified potential sites in the viral genetic material for targeted anti-viral therapy and 
uncovered two potential mechanisms of persistent infection. Most excitingly, they have 
discovered a potent specific antiviral molecule, a ribozyme that cleaves a vulnerable site within the 
viral replication gene and blocks virus propagation. Coronaviruses infects and produces serious 
disease in cattle and Brian's research provides potential opportunities for resolving the acute and 
chronic coronavirus infection problems in cattle, but has applications for controlling coronavirus 
infections in humans as well . 
Dr. Jack Oliver's area of research emphasis continues to be the understanding and 
control of the adverse effects associated with animals consuming toxic tall fescue grass. Tall 
fescue is grown on 3.5 million acres in the State of Tennessee, and most of this grass is infected 
with a fungus that produces toxins that harm animals (cattle, horses, sheep) that consume the 
grass. Conservative estimates place the animal loss to Tennessee cattle producers alone at nearly 
$100 million. In conjunction with other researchers at the University of Tennessee and the 
Agricultural Experiment Station, Dr. Oliver's major activity has been concerned with a field-trial 
study to determine the effectiveness of a for preventing tall fescue toxicosis. Results of this study 
proved that a vaccine approach to the control of fescue toxicity was possible. 
The overall research focus in Dr. Philip Bochsler's laboratory has been the investigation 
of bacterial diseases of cattle. The general purpose of this research is to gain a better 
understanding of host-defense responses of cattle to disease-producing organisms. A better 
understanding of these responses is essential for understanding the pathogenesis of important 
diseases of cattle, and is important for the ultimate goal of designing improved strategies to deal 
with these diseases. In his work, he has studied the regulation of nitric oxide synthesis and is in 
the process of characterizing the role of nitric oxide in host defense against bovine respiratory 
tract disease-producing organisms. 
Goal 2 ­




Drs. P. Bochsler, S. Oliver, J. Oliver, L. Potgieter, D. Brian, J. Godkin, L. Munson, 
and J. Merryman made significant contributions in livestock disease research by the Center this 
past year. 
Dr. Philip Bochsler's study of nitric oxide produced by certain cells and its potential 
disease-producing role in the bovine lung will elucidate molecular mechanisms involved in the 
bovine defense response to disease organisms, and will add useful information concerning the 
development of some respiratory diseases of cattle. Bacterial and viral infections of the 
respiratory tract of cattle occur commonly in Tennessee, and are a source of significant economic 
loss to the cattle industry. He has established that nitric oxide may be an important regulatory 
molecule affecting the host-defense response of cattle to microbes. 
Further recognition for the feasibility of an immunological approach to the control of 
fescue grass toxicity occurred when Dr. Jack Oliver and co-workers were issued a patent for a 
vaccine to control fescue toxicity in animals (U.S . Patent No. 5,468,486, November 11, 1995). A 
comprehensive approach to monitoring toxin effect on normal body function of animals included 
documenting changes in the appearance of animals, recording body weight changes, and 
measuring a wide array of metabolic factors. This represented the most thorough study of tall 
fescue toxin effect on cattle that had ever been done. Animals that were grazing toxic tall fescue 
grass without benefit of vaccine, when compared to vaccinated cattle, grew at a slower rate, had 
evidence of suppressed liver function (certain metabolic enzyme levels were less), and had bone 
marrow suppression (total white blood cells and total red blood cells were less). 
Dr. Leon Potgieter's work focused on the genetic variability of Respiratory Syncytial 
Virus strains recovered from cattle and sheep. A portion of the viral gene that varies among 
strains was targeted with a probe designed to react with the appropriate genetic material. He 
determined that two subgroups of the virus affecting these animals existed. This work suggests 
that a vaccine made with one strain of the virus might not provide adequate protection against 
respiratory disease caused by the virus. 
Dr. David Brian continued to work on bovine coronavlrus, concentrating on the 
molecular biology of its replication. With funding from the USDA and the NIH, Dr. Brian has 
been making an intense and systematic effort to understand how five separate genetic structural 
elements in the coronavirus genome function to regulate production of viral proteins. During 
acute infection, replication rates are high and during persistent infection, replication rates are low. 
He studied the mechanism by which the five specific (untranslated) regions on the 
messenger molecules (RNA' s) regulate the rate of viral protein synthesis (translation). They now 
have obtained new information about coronaviruses that defines a specific site regulating viral 
protein synthesis. This site, therefore, could be targeted for therapeutic control of coronavirus 
infection. 
Dr. Linda Munson's work on the development of a mouse model of endometriosis and 
to test the role of a specific growth factor (platelet cell-derived) in the initiation and maintenance 
of endometriosis has been successful. She has made significant progress in developing and 
characterizing cell lines of human endometrial epithelial cells, optimizing their methods for 
identifying key proteins (peptides) and receptors in these cells. She confirmed that the growth 
factor receptors are present in human endometriotic tissues and strengthened the relevancy of the 
growth factor hypothesis. She also has made progress in transplanting endometrial cells into the 
mouse and confirming the continued expression of growth factor receptors in the transplanted 
cells. Transplanted cells are identified as human endometrial epithelial cells in the mice by tests 
with a monoclonal antibody which does not react with mouse tissues. 
Recent studies by Dr. James Godkin have focused on the factors that influence early 
embryonic development leading to successful pregnancy in cattle and sheep. Vitamin A (retinol) 
is essential for reproductive processes. Severe retinol deficiency may inhibit reproduction cycles, 
ovarian development, and ovulation. Moderate deficiency may result in abortion, fetal resorption 
or congenital abnormalities. Dr. Godkin studied the mechanisms by which retinoids (vitamin A­
like chemicals) regulate cell growth and development in reproductive tissues. Recent discoveries 
include the identification of retinol-binding protein (RBP), cellular-retinol binding protein (CRBP) 
and cellular-retinoic acid binding protein (CRABP) in the placenta, uterus, oviduct, ovarian 
follicle, egg and corpus luteum of cattle and sheep. He determined the role of ovarian sex 
hormones and retinol derivatives in regulating synthesis of retinol-associated proteins in these 
tissues. Research in progress is focused on developing treatments to manipulate production of 
these critical proteins during ovulation and pregnancy to achieve improved reproduction 
efficiency. 
In addition to the studies of retinol-associated proteins, it was discovered that the uterus 
and placenta of sheep and cattle produce a family of growth factors known as transforming 
growth factor-beta. Three members of this family (TBF-B-l , B2, B3) and their messenger 
molecule (mRNA) are produced at different concentrations in the uterus during the estrous cycle 
and pregnancy. Sex hormone replacement studies demonstrated that each growth factor is 
regulated differently by ovarian hormones. 
A major research focus of Dr. Stephen Oliver has been on the bacterium Streptococcus 
uberis, a frequent cause of mastitis in cows. Strategies for controlling this mastitis-causing 
organism are poorly defined and currently inadequate. During the last year, Dr. Oliver's 
laboratory has identified some factors that allow Streptococcus uberis to invade the udder and 
produce mastitis. One such factor is a capsule composed primarily of hyaluronic acid that 
surrounds bacteria in at least 50% of strains, and that inhibits bacterial destruction by mammary 
gland macrophages (scavenger cells) . Another factor is a protein that may promote adherence of 
this organism to certain cellular proteins and to mammary epithelial cells. He hypothesized that 
the capsule and the protein are virulence factors involved in the development of Strep. uberis 
mastitis. The long-term goal of this research is to develop a vaccine to control this important 
mastitis-producing organism. 
Certain malignant tumors (squamous cell carcinomas) are common in people and are often 
associated with environmental stresses such as ultraviolet radiation, cigarette smoke, and other 
carcinogens. Squamous cell carcinomas probably develop because their cells are not inhibited by 
a certain growth factor (TGF-p 1). This appears to be a mechanism by which normal epithelial 
cells become malignant. Studies conducted by Dr. Joyce Merryman confirmed the resistance of 
squamous cell carcinomas to growth-inhibition normally induced by this growth factor. But these 
cells still respond by activating production of certain chemical signals within the cell . This led to 
the discovery that the growth factor was incapable of activating the normal mechanisms for 
repairing DNA in the tumor cells exposed to ultraviolet light. The repair mechanism is activated 
by the growth factor in normal cells under similar circumstances. This fundamental research may 
identify mechanisms for controlling the tumors . 
Goal 3 ­
To Identify and Characterize Animal Diseases that are Analogous to Human 
Diseases 
Dr. Eric Schultze's research focused on characterizing the results of genetic changes in a 
region called the fitness 1 locus in chromosome 7 of mice. Mice with mutations in the fitness 1 
locus are stunted and develop growth abnormalities involving the spinal column (scoliosis). 
Fitness 1 mice also have a marked deficiency in the number of red blood cells (anemia) and 
evidence of liver dysfunction. Work in the laboratory centered on the investigation of iron 
metabolism, a requirement for normal blood cell formation and bone growth. 
Fitness 1 mice had less iron in their blood than normal mice do . The concentration of iron 
in the liver offitness 1 mice was increased, but the concentration of iron within the kidneys was 
significantly less than that of normal mice. From these data, it was concluded that the anemia in 
fitness 1 mice is associated with abnormal iron metabolism. The evidence of excessive storage of 
iron within the liver, low serum iron concentration and biochemical evidence of liver dysfunction 
suggests that the fitness 1 mouse is a good model for the disease hemochromatosis. Thefitness 1 
mice constitutes a unique model that can be used to shed new light on the diagnosis and treatment 
of anemia and hemochromatosis in people. This research has broad implications for 
understanding the molecular control of blood cell formation, iron metabolism, and bone growth in 
mammals. 
Tennessee is one of the top five air polluting states in the nation. To aid industry, state, 
and local governments in making accurate judgments regarding chemical toxicity methods 
predicting toxicity of chemicals such as quantitative structure-toxicity relationships and 
knowledge-based expert systems, need to be developed. Phenols are a group of poisonous 
bioreactive organic chemicals that have a wide variety of industrial uses. Bioreactive chemicals, 
such as phenols, cause unique problems for the development of methods that predict toxicity of a 
chemical. 
Over the past year, Dr. Terry Schultz's laboratory has focused on developing models of 
predicting chemical interactions of industrial phenols. His laboratory has found that certain 
chemical properties (the ionization constant and the quantum chemical molecular orbital term, the 
lowest unoccupied molecular orbital energy) are important in predicting toxic potency of phenols. 
Goal 4 ­
To Study Animal Models for Better Understanding of Human Disease 
Several COE researchers exploited animal models in their studies over the past year of 
disease processes in humans. The investigators were Drs. C. Mendis-Handagama, Dr. T. 
McDonald, J. Sackman, B. Rouse, H. Schuller, E. Schultze, D. Ward, and E. Wilkinson. 
Dr. Charmi Mendis-Handagama continues her research on cellular mechanisms 
associated with hormone production in the mammalian testis and ovary using the rat model. 
Mouse models are extensively used by Dr. Barry Rouse and co-workers in their studies 
of the immuno-biology of human herpesvirus type 1 (herpes simplexvirus). The objectives of their 
work are to understand the mechanisms of the disease processes and protective immunity and the 
development of effective vaccines. Significant progress was made this past year. 
Dr. Hildegard Schuller has been studying the role of the autonomic nervous system in 
the induction and development of lung cancer. It has been known for years that nicotine 
stimulates brain cells because it binds to a certain receptor (nicotinic acetylcholine receptor) of the 
autonomic nervous system. Dr. Schuller has found also that this receptor is produced on some 
types of lung cells that give rise to the most common human lung cancers and that it regulates the 
growth of these cells. Nicotine is generally considered non-carcinogenic based on experiments in 
laboratory animals. However, it is becoming increasingly evident that, among smokers, only those 
who have a history of chronic lung disease are at high risk to develop lung cancer. Dr. Schuller 
has simulated this condition in hamsters maintained in an environment with concentrations of 
oxygen that are toxic to the lung. These animals developed lung cancer when given nicotine at a 
concentration (0.1 mg/Kg two times/week) equivalent to that in a moderate smoker. Healthy 
animals without lung injury did not develop tumors when treated with nicotine. These results 
prove, for the first time, that nicotine can cause lung cancer in individuals with chronic lung 
disease. 
Another important finding in Dr. Schuller's laboratory was that theophylline blocks the 
growth of small cell lung cancer in the laboratory while it stimulates the growth of another lung 
cancer (adenocarcinoma) The mechanism by which theophylline regulates these two lung cancers 
is being studied in animal models. Theophylline is the active ingredient in drugs that dilate the 
bronchi and that are widely used for the treatment of asthma and bronchitis. High concentrations 
of theophylline are contained also in black and green tea. If the animal experiments confirm the 
laboratory data, theophylline containing drugs, as well as tea should be avoided by human patients 
with lung adenocarcinoma whereas they would be beneficial for the treatment and for the 
prevention of metastatic spread of small cell lung cancer. 
Dr. Jill Sackman is using a dog model to investigate gene therapy via cells that line the 
blood vessels (endothelial) cells. However, genetically-altered endothelial cells generally fail to 
adhere to blood vessel grafts used as a vehicle to deposit the cells in an animal. She has 
determined that the mechanism for poor adhesion is an altered or missing receptor on the cells. 
This information now allows the development of methods to circumvent the problem and will 
enhance the development of gene therapy to treat genetic vascular diseases in humans. 
Dr. Ted McDonald's laboratory continues to work on the genetic basis of a disease of 
blood cells, the abnormal production of blood platelets. Certain precursor cells (megakaryocytes) 
that give rise to blood platelets may contain excessively-high numbers of chromosomes and result 
in over-production of blood platelets that may promote vascular disease. The mechanism by 
which this condition is inherited in mice has been determined and now the role of genetic control 
and thrombopoietin (a hormone affecting megakaryocytes) can be evaluated to establish potential 
mechanisms of controlling the disease. 
Dr. Erby Wilkinson continues to focus on the development of disease caused by specific 
genetic mutations, and has exploited several mouse models for these diseases; either spontaneous 
mutant mice or mice in which mutations have been induced in the laboratory. Dr. Wilkinson has 
made some significant discoveries concerning the genetic kidney disease (autosomal recessive 
polycystic kidney disease) . It is caused by a change in a specific gene that may be important in 
cell cycle regulation. He identified a unique protein that this gene codes for. Furthermore, he 
discovered cells in the liver of these mice that have characteristics of liver stem (precursor) cells 
making these mice good candidates for studies of liver cancer. 
Dr. Wilkinson has also identified a mouse model of auto-immune disease caused by 
abnormalities in the interaction among certain lymphocytes in the developing thymus of the mouse 
embryo. He is investigating the cellular and molecular basis of the disease by specific laboratory­
induced mutations in these mice. Further studies this past year include the identification of mouse 
models of a variety of other genetic diseases affecting various tissues and organs. 
Dr. Daniel Ward continues his research in the treatment of abnormal eyelashes 
(distichiasis) that cause eye irritation and the treatment of elevated intraocular pressure 
(glaucoma). Using a dog model, his laboratory has conclusively demonstrated that surgical 
placement of a fluid-draining device is superior to laser surgery for the treatment of severe 
glaucoma. 
Goal 5 ­
To Understand the Pathogenesis and Characterize the Causative Agents of 

Common Diseases Important to the State of Tennessee 

The research focus of many COE investigators is to dissect mechanisms and causes of 
disease production in animals and humans. Researchers who contributed significantly to this field 
over the past year included Drs. P. Bochsler, D. Brian, T. McDonald, J. Merryman, J. 
Oliver, S. Oliver, B. Rouse, H. Schuller, T. Schultz, E. Schultze, D. Ward and E.Wilkinson. 
Dr. Barry Rouse and co-workers have moved closer to understanding how herpes 
simplex virus infection of the eye causes an inflammatory reaction (herpetic stromal keratitis) 
which often results in blindness. It seems that the virus replicates in the surface epithelial cells of 
the cornea and this causes the release of chemical messengers, chemokines, which signal certain 
white blood cells (neutrophils) to enter the cornea. Although these cells are mainly confined to 
the deeper layers of the cornea (i .e., in the stroma), they are responsible for clearing virus. How 
they accomplish this is currently under study. Dr. Rouse has evidence that either the viral 
replication events or the antiviral efforts of the neutrophils damage the corneal tissues in such a 
manner that triggers the host's own defense system to react with these tissues resulting in chronic 
autoimmune disease. Herpetic stromal keratitis may well represent an auto-immune inflammatory 
response set off by viral infection. Repair of the lesion leaves a scarred cornea that acts as screen 
to light transmission and in thus partial or complete blindness. 
Dr. Jack Oliver and co-workers have developed and refined a model assay system for 
the effects of tall fescue grass toxin on blood vessel (endothelial) cell function . Two of the major 
tall fescue compounds (alkaloids: ergine and ergovaline) were toxic to these cells. Presumably 
they affect endothelial cells of animals leading to the chronic inflammatory state responsible for 
tall fescue toxicity in cattle. Tall fescue toxicity may result in suppression of liver and bone 
marrow function and of the immune response which could explain the superior weight gain in 
cattle given a newly-developed vaccine against these toxins. 
A test in ferrets, based on measuring adrenal hormones before and after stimulation of the 
adrenal glands, was developed in Dr. Oliver's laboratory to detect cancerous growth of these 
glands. Results of thyroid function testing in parrots indicates that stimulation of the birds with 
thyrotrophic releasing hormone will allow diagnosis of certain thyroid conditions. This test will 
be invaluable to detecting the most common hormonal disorder in birds because standard thyroid 
tests are too variable. No other thyroid stimulation tests are currently available for birds, so the 
new test procedure is an important development for improving the health of birds. 
Dr. Daniel Ward has investigated factors that affect the ability of the pigmented 
epithelium of the retina to protect the interior of the eye from blood-borne toxicants. Similarly, he 
has shown that a certain growth factor which is produced in the eye and other tissues, also 
provides protection. 
Goal 6 ­
To Improve the Capabilities of the College of Veterinary Medicine, the College 

of Agricultural Sciences and Natural Resources, and the Agricultural 

Experiment Station to Deal with these Diseases 

Dr. Barry Rouse's work with naked DNA vaccines, and inclusion within vaccines the 
DNA encoding regulatory molecules of the immune system, has been mentioned elsewhere in this 
report. However, it needs to be emphasized that this approach promises to greatly enhance the 
effectiveness of vaccines and to develop vaccines to protect against a variety of diseases for which 
vaccines have not been available in the past. Similarly, work in Dr. David Brian's laboratory has 
resulted in the discovery of another powerful mechanism to deliver substances to an animal to 
induce immunity. They found that a defective portion of a coronavirus of cattle was incapable of 
producing disease but still had the capacity to divide in cells. This subviral replicon can be used, 
not only to immunize animals to coronavirus, but also to carry other immunizing proteins or 
therapeutic drugs into animals' tissues. 
Dr. Jack Oliver, together with his co-workers, have collected additional information on 
the efficacy of a novel vaccine to prevent the toxic effects of alkaloids present in tall fescue grass. 
A patent has been issued for this vaccine and several commercial companies have expressed an 
interest in further development of this vaccine . 
Data from Dr. Robert Shull's laboratory indicate the exciting prospect that curing certain 
genetic diseases by gene therapy involving a certain carrier virus is possible. In this project they 
used a harmless virus, adeno-associated virus, to carry the appropriate genetic material into and to 
restore the genetic defect in the tissues of dogs. 
Goal 7 ­
To Improve Facilities to Enable the College of Veterinary Medicine to Study 

More Effectively Infectious and Toxic Diseases of Animals 

As mentioned in last year's report, space in the Clyde M. York Veterinary Medicine 
Building for research, teaching, and clinical services is in short supply. Collaborative COE 
research is being conducted also in McCord Hall (Animal Science), Walters Life Sciences 
(Microbiology), and in the Oak Ridge National Laboratory; but research space everywhere is at a 
premium. It appears that funding for an animal housing facility at Cherokee Farm is now in place. 
Construction should proceed this fall . Once the facility is completed, the veterinary student 
surgery will be moved to Cherokee Farm, thereby, freeing approximately 3,000 square feet, some 
of which will be designated for research space. Minor renovations and equipment allocations 
have been made over the past year to maximize efficient use of space and to promote a multi-user 
philosophy. Laboratory sharing among facuIty with similar interests and/or similar equipment 
requirements has been encouraged and implemented. 
Goal 8 ­
To Disseminate Through the Extension Service Practical Information 
Required to Reduce the Incidence of Livestock Diseases 
The efforts of Dr. Nancy Howell, (public information coordinator), the veterinary 
extension personnel, and researchers continue to ensure that the College of Veterinary Medicine is 
featured in many national, regional, and state-wide publications. Research projects and data 
pertinent to Tennessee interests constitute a significant proportion of the media releases and 
informational displays. Many of the research articles featured were written by COE personnel, 
who have also taken advantage of invitations to speak to commodity groups at Tennessee 
Agricultural Experiment Station field days and at formal extension service programs. Publications 
have appeared in UT Agriculture (published for a state-wide readership by the Institute of 
Agriculture), Veterinary News (for practitioners), Veterinary Medical Topics (published twice 
yearly by the extension service), and two alumni publications (UT Alumnus and Torchbearer), and 
in Context (UT faculty/staff newsletter). Research being conducted by the Center is disseminated 
also via a computer-based program, the World-Wide Web. The University of Tennessee, College 
of Veterinary Medicine has a home-page (http ://www. vet. utk. edu/vet/ default. html) . 
Goal 9 ­
To Develop New Strategies for the Prevention of Disease 

Dr. Barry Rouse has been investigating DNA vaccmes composed of laboratory­
propagated DNA that encodes proteins of herpes simplex virus as well as proteins that act to 
regulate the immune response. His laboratory was the first to show that genetic vaccines could 
induce protective immunity against the virus and more recently have demonstrated that DNA 
encoding HSV proteins can produce immunity in the reproductive tract following intra-nasal 
immunization. This opens up the prospect of developing a new approach to the control of the 
virus, an important venereal disease. Recent experiments have also revealed that the inclusion of 
DNA encoding molecules that regulate the immune system may markedly influence the nature and 
effectiveness of the immune response. These findings have far-reaching implications in the 
production ofvaccines. 
Work done in the laboratories of Drs. Jack Oliver, Hildegard Schuller, and David 
Brian may also culminate in novel strategies for preventing infectious diseases, certain toxicities, 
and cancer (see information under Goals 4 and 6). 
Goal 10 ­
To Improve Facilities and Expertise in Order to Provide Improved Research 
Training 
Equipment 
As in previous years, several multi-user pieces of equipment were bought for COE 
researchers over the past year. Strategic equipment purchases last year include a Coulter 
multi sizer cell counter and an image analysis system. This equipment should enhance significantly 
the capacity of researchers to work with cells in the laboratory and to record and analyze nucleic 
acid or protein data. 
Graduate Students and Postdoctoral Researchers 
In the past, the training component of the Center of Excellence has been small, but one of 
high quality. This past year, funds were used to support stipends for graduate students or 
postdoctoral researchers for Drs. Brian, Godkin, S. Oliver, Rouse, Schuller, and Wilkinson. 
A major achievement by the Center of Excellence has been the funding by the National 
Institutes of Health of a large institutional training grant. The success of this grant application 
was largely due to the efforts of Dr. David Slauson, the primary author of the proposal. The 
grant will support five selected graduate students/residents in the Comparative and Experimental 
Medicine Graduate Program. The training program will be a collaborative effort of the 
Department ofPathology and the biology division of the Oak Ridge National Laboratory, and will 
emphasize "cellular pathobiology of environmental disease ." The central goal of this training 
effort is to provide outstanding research opportunities for young pathologists in highly focused 
quality research laboratories with excellent quality control. Dr. Karrie Brenneman is 
completing her first year in the program and will be reappointed for her second year. She is 
working in the laboratories of Dr. Erby Wilkinson and Dr. Rick Woychik. Her doctoral 
research will involve mice with specific experimentally-induced genetic disease. 
Dr. Barbara Sheppard is the second trainee, and was appointed July 1, 1996. Dr. 
Sheppard has special interests in diseases of the nervous and immune systems. She hopes to work 
on the development of diseases at cellular and molecular levels. 
Four graduate students and seven residents received modest COE support for their 
research. Funds were allocated on a competitive basis. 
Nine faculty also received modest funding for "venture" grants. The criteria for allocating 
the latter included scientific merit and potential of the work to lead to future funding. 
Goal 11 ­
To Develop Innovative Approaches to the Treatment of Human Disease 

Dr. Kevin Hahn's research concerns reversing the resistance of some tumors to 
anticancer drugs. Using dogs with lymphoma as an animal model, Dr. Hahn and co-workers 
have identified how the tumor cell environment affects the cell's response (survival or death) to 
the anticancer drug. These results have led Dr. Hahn and co-workers to pursue further research 
to identify, develop, and evaluate new drugs which may change the tumor environment allowing 
anti-cancer drugs to be more effective in treating drug-resistant tumors. 
Dr. Robert Shull continues to make progress in research concerning restoration of a 
genetic defect in children (mucopolysaccharidosis I enzyme deficiency) in a dog model of the 
disease. In collaboration with Dr. Emil Kakkis, the long-term effects of genetically-engineered 
products administered to reconstitute the function of the gene in dogs were studied. This year 
new emphasis was placed on investigation of gene therapy administered into muscle. Five dogs 
were treated with the important conclusion that such gene therapy can be severely limited by an 
immune response to the desired enzyme produced in animals. 
Another exciting project involved direct intramuscular injection of a novel harmless carrier 
virus (vector) constructed from adeno-associated virus. The vector contained the genetic material 
encoding the enzyme missing in affected dogs. Tissues of the treated animals contained high 
levels of the desired enzyme, and the stage now has been set for exploring adeno-associated virus­


























FACULTY MEMBERS ASSOCIATED WITH THE CENTER OF EXCELLENCE 

YearS Year 6 Year 7 Year 8 Year9 Year 10 Year 11 Year 12 
(Final Year of (Year 01 as (Year 02 as (Year 03 as (Year 04 as (Year 05 as (Year 06 as (Year 07 as 
Initial Accomplished Accomplished Accomplished Accomplished Accomplished Accomplished Accomplished 
Commitment Center) Center) Center) Center) Center) Center) Center) 
Center) 1989-1990 1990-1991 1991-1992 1992-93 1993-94 1994-95 1995-96 
1988-1989 
Target Actual Avg Actual Avg Actual Avg Actual Avg Actual Avg Actual Avg Actual Avg Actual Avg 
Number of: 
Articles 74 (3.22) 68 (2.62) 97 (3.73) 83 (4.37) 78 (3.90) 95 (5.00) 132 ( 6.29) 153 ( 7.29) 
Books or Book Chapters 7 (0.30) 17 (0.65) 14 (0.54) 6 (0.32) 7 (0.35) 9 (0.47) 5 (0.24) 5 ( 0.27) 
Published Proceedines 21 (0.91) 37 (1.42) 42 (1.62) 24 (1.26) 17 (0.85) 11 (0.58) 37 (1.76) 65 ( 2.95) 
Total Publications 2.82 102 (4.43) 122 (4.69) 153 (5.89) 113 (5.95) 102 (5.10) 104 (5.47) 174 (8.29) 223 (10.62) 
Abstracts 0.30 33 (1.43) 66 (2.54) 48 (1.85) 47 (2.47) 53 (2.65) 55 (2.89) 42 (2.00) 64 ( 3.05) 
Invited Participation at: 
Reeional Meetings 0.50 36 (1.56) 19 (0.73) 28 (1.08) 13 (0.68) 15 (0.75) 18 (0.95) 41 (1.95) 55 ( 2.62) 
National Meetings 1.25 55 (2.39) 28 (1.08) 44 (1.69) 36 (1.89) 47 (2.35) 47 (2.47) 65 (3.10) 70 ( 3.18) 
Faculty in Center 23 26 26 19 20 19 21 22 
Number of Visitors 11 10 17 17 12 12 13 15 18 
TABLEJ 

RESEARCH PROJECTS FUNDED EXTERNALLY 









Philip Bochsler The role of nitric oxide as a mediator of host 
defense in cattle. 
USDA 1433 Funds $ 6,852.00 
10/1/95-9/30/96 
Purification and characterization of bovine 
lipopolysaccharide-binding protein (renewal) 
USDA $ 184,000.00 
9/1/93-8/31/96 
$ 55,279.67 
Molecular basis of endothelial cell sensitivity 
to lipopolysaccharide 
USDA $ 95,000.00 
9/15/92-8/31/95 
$ 3,935.46 
David Slauson (Co-PI) The bovine CD 14 receptor: A link in 




David Brian Bovine coronavirus vector for mucosal 




Mechanisms of coronavirus RNA 
amplification. 





Mechanism(s) of coronavirus RNA 




J ames Godkin Retinoids in bovine follicular and oocyte 
development 
USDA Formula Funds $ 5,000.00 
10/1/95-9/30/96 
--- ­
Retinoid-binding protein and receptors in 













Treatment of dogs with spontaneously 
occurring osteogenic sarcoma 
Phase II evaluation of oxorubicin in the cat 
Development of assays for thrombopoietin 
Characterization of thrombopoietin 
Regulation of testosterone production in adult 
rat testis 
Contraceptive health surveillance center for 
zoo and wildlife species. 
Continuing safety assessments of 
contraceptives for non-domestic felids 
Characterization of serum clinical chemistry 
analyte profiles of cattle grazing endophyte­
free and endophyte-infected tall fescue grass. 
Anti-fescue toxicosis vaccine study (Co-PI) 
Endothelin response to tall fescue stimulus of 
bovine endothelial cells (Co-PI) 
Identification, characterization, and 
evaluation of Streptococcus uberis virulence 
factors 
Efficacy of two novel experimental 
postrnilking teat disinfectants for the 
prevention of mastitis in dairy cows under 
natural exposure conditions 
BYK Gulden 




National Science Foundation 
Geraldine R. Dodge Foundation 
American Association of Zoo Parks 
and Aquarium 
USDA 1433 Funds 
Merck and Company 
USDA 
USDA Formula Funds 
Farnam Companies, Inc. 
$ 63,890.00 $ 9,221.14 
1993-96 
$ 10,000.00 $ 9,782.13 
1994-96 




$ 18,000.00 $ 5,022.69 
8/15/94-1/31/97 
$ 30,000.00 $ 12,286.11 
10/95-9/96 










$ 69,600.00 $ 499.95 
1995-96 
Stephen Oliver (cont'd) 
Leon Potgieter 
Barry Rouse 
Application of DNA markers to assess the 
gene associated with high somatic cell count 
and mastitis in Jersey cattle 
DNA fingerprinting of mastitis pathogens 
Experimental infection of bovine mammary 
glands with Strep. Uberis 
Influence of intramammary antibiotic therapy 
at calving on mastitis and lactational 
performance of heifers during early lactation 
Significance of strain variation within the 
ruminant respiratory syncytial virus 
Amplification, cloning, and expression of 
structural protein genes of BVD virus 
Identification of C3 binding components that 
facilitate invasion by Babesia bigemina 
(Co-PI) 
Detection of feline infectious peritonitis virus 
and feline enteric coronavirus (Co-PI) 
Immunity mechanisms in herpesvirus 
infections 
Mucosal immunity in control of herpetic 
infection 
Mechanisms of herpetic stromal keratitis 
Genetic vaccines and immunity to herpes 
simplex 
Liposome microencapsulation of vaccine 
antigens 
American Jersey Cattle Association 
Dairying Research Corporation 
Sanofi Animal Health 
The Upjohn Company 
USDA 
The Upjohn Company 
USDA 
Morris Animal Foundation 
National Institute of Allergy and 
Infectious Diseases - NIH 
National Institute of Allergy and 
Infectious Diseases - NIH 
National Eye Institute - NIH 
NIH 
NIH 
$ 6,400.00 $ 6,400.00 
1995-96 
$ 3,000.00 $ 3,000.00 
1995 
$ 20,200.00 $14,999.51 
1995 
$ 38,250.00 $17,069.00 
1995 
$123 ,310.00 $ 14,056.12 
9/1/93-8/31/95 






















Evaluation of the mechanisms of genetically 
modified endothelial cell loss from synthetic 
vascular grafts in vivo 
NNK effects on receptor pathways in normal 
and neoplastic lung cells 
Regulation of the proliferative response of 
pulmonary neuroendocrine cells to nicotinic 
agonists 
Anticarcinogenic effects of dexniguldipine-
MCL in hamsters 
Characterization of induced neuroendocrine 
lung cancer 
Structure-biodegradability/toxicity 
relationships of substituted naphthalenes 
Development ofbioremediation risk 
management 
Photo-induced toxicity in Tetrahymena 
Molecular study of MPSI; gene therapy in a 
canine model 




Mammalian genetics and development 
American Heart Association 
National Cancer Institute - NIH 
Verum Foundation for Behavior and 
Environment 
BYK-Gulden, Inc. 
National Cancer Institute - NIH 
Dupont Corp. 
Environmental Protection Agency 
University of Minnesota 
University of California - Nlli 








$128,484.00 $ 15,552.17 
1/10/96-12/31/97 
$380,133.00 $ 35,897.25 
1/ 1/9 3 -12/31/96 




$ 34,749.00 $ 23,276.47 
9/94-9/96 
$ 19,063 .00 $ 6,815.16 
1/1/94-12/31/96 
$255,055 .00 $125,940.86 
8/1/94-7/31/98 
$117,496.00 $ 40,736.84 
7/1/95-6/30/00 
$ 67,700.00 $ 34,028.67 
7/1/95-12/31/96 
$ 41 ,391.00 $ 20,64l.74 
10/1/95-9/30/96 
$ 70,850.00 $ 48,925.48 
10/1/95-9/30/96 
Wilkinson (cont'd) 	 Role of the agouti gene product on Lockheed Martin $ 37,790.00 $ 26,185.94 
tumorogenesis 10/1/95-9/30/96 
Histopathologic and clinical pathology Lockheed Martin $175,600.00 $ 32,792.80 
analyses of mice from a colony containing 7/1/95-3/21/98 
chromosomal translocations 
Genome analysis program Lockheed Martin 	 $ 29,390.00 $ 8,156.46 
2/1/96-9/30/96 
D. Slauson Co-PI Directed expression of the agouti gene Glaxo $672,890.00 $368,572.47 
product in transgenic mice: A potential 10/1/93-9/30/96 
model for obesity 
Small instrumentation grants program NIH 	 $ 18,615 .00 $ 2,089.30 
9/1/94-8/31/95 
Molecular genetics and PKD in the NIH $484,523.00 $ 58,340.30 
transgenic TG737 mouse 9/30/93-9/29/95 
Barry Rouse (Co-PI) 
Immunobiology of the scurfy mouse NIH $691 ,666 .. 00 $ 6,090.13 
9/30/92-5/31/95 
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Assistant Professor 
Department of Pathology 
David A. Brian, D.V.M., Ph.D. 
Professor 
Department of Microbiology 
James D. Godkin, Ph.D. 
Professor 
Department of Animal Science 
Kevin A. Hahn, D.V.M., Ph.D. 
Associate Professor 
Department of Comparative Medicine 
Diane Hendrix, D.V.M. 
Assistant Professor 
Department of Small Animal Clinical Sciences 
Melissa Kennedy, D.V.M., Ph.D. 
Instructor 
Department of Comparative Medicine 
Allen G. Mathew, Ph.D. 
Assistant Professor 
Department of Animal Science 
Charmi Mendis-Handagama, D.V.M., Ph.D. 
Assistant Professor 
Department of Animal Science 
Joyce I. Merryman, D.V.M., Ph.D. 
Assistant Professor 
Department of Pathology 
Darryl L. Millis, M.S., D.V.M. 
Assistant Professor 
Department of Small Animal Clinical Sciences 
Linda Munson, D.V.M., Ph.D. 
Assistant Professor 
Department of Pathology 
Jack W. Oliver, D.V.M., Ph.D. 
Professor 
Department of Comparative Medicine 
Stephen P. Oliver, D.V.M., Ph.D. 
Associate Professor 
Department of Animal Science 
Sharon Patton, Ph.D. 
Professor 
Department of Comparative Medicine 
Leon N.D. Potgieter, B.V.Sc., Ph.D. 
Professor and Head 
Department of Comparative Medicine 
Barry T. Rouse, B.V.Sc., Ph.D. 
Professor 
Department of Microbiology 
Jill E. Sackman, D.V.M., Ph.D. 
Assistant Professor 
Department of Small Animal Clinical Sciences 
Dorcas O. Schaeffer, D.V.M., M.S. 
Assistant Professor 
Department of Comparative Medicine 
Hildegard M. Schuller, D.V.M., Ph.D. 
Professor 
Department of Pathology 
Terry W. Schultz, Ph.D. 
Professor 
Department of Animal Science 
A. Eric Schultze, D.V.M., Ph.D. 
Assistant Professor 
Department of Pathology 
David O. Slauson, D.V.M., Ph.D. 
Distinguished Professor and Head 
Department of Pathology 
Daniel A. Ward, D.V.M., Ph.D. 
Assistant Professor 
Department of Small Animal Clinical Sciences 
J. Erby Wilkinson, D.V.M., Ph.D. 
Associate Professor 
Department of Pathology 
Center of Excellence 
1996-97 
No major changes in the direction of research within the Center are anticipated for the 
next year. Most researchers have embarked on long-term research goals and some less­
established members are focusing on development of a fundable research niche. Generally, the 
Center's research falls within two categories, livestock diseases or animaillaboratory models of 
human diseases . Researchers have concentrated on a limited number of focus areas within these 
two broad categories (Livestock diseases: infectious diseases/population medicine, toxicoses and 
reproduction; Animal models: host defense, molecular genetics and carcinogenesis). 
The general research goals for each of the research focus groups are as follows : 
Infectious Diseases/Population Medicine 
Dr. Brian's laboratory will focus on the understanding of the mechanisms used by 
coronaviruses for regulating genome replication and gene expression. 
Dr. S. Oliver will identify virulence factors that play an important role in the development 
of S. uberis mastitis and to determine whether such factors must be considered in the development 
of a vaccine to control this organism. 
Dr. Potgieter will work on preventing respiratory tract disease in cattle caused by 
respiratory syncytial virus infections. He hopes to determine whether current vaccines are capable 
of producing an adequate immunity to the disease because circumstantial evidence suggests that 
vaccines are inadequate under certain circumstances. 
The Center also funded two projects; one on the mechanisms by which certain bacteria 
causing food-borne diseases establish themselves in the intestine in swine (Dr. A. Mathew) and 
the other on the implications of infections in swine with Toxoplasma gondii (an important 
parasitic disease of the nervous system and fetuses in humans) as a food-borne illness. 
Toxicoses 
Dr. T. Schultz will work on laboratory models capable of predicting toxicity of 
bioreactive phenols. This project will provide quantitative experimental toxicity data for a number 
of important industrial and environmental chemicals. 
Dr. J. Oliver and co-workers will study the effect of tall fescue grass toxins on blood 
vessels of cattle. Chronic exposure to the toxins results in damage to the lining of blood vessels 
and mechanisms to prevent damage will be investigated. They also will work on improving the 
their patented vaccine to prevent the harmful effects of the toxins. 
Dr. Ward will investigate the effects of certain growth factors (bFGF, TGFB) and 
chemical factors on a laboratory model of the protective outer blood-retinal barrier in the eye. It 
is hoped that he can establish the same barrier that exists in the eye for protection against blood-
borne toxins . 
Reproduction 
Dr. Godkin will conduct studies on methods that regulate the effect vitamin A-like 
chemicals (retinoids) on ovarian function and early embryonic development. The long-term goal 
of these studies is to identify means of improving reproductive efficiency in livestock. 
Dr. Munson will study the effect of a certain growth factor (PDGF) on the development 
of endometriosis, a cause of infertility. 
Host Defense 
Dr. Rouse will continue to work on the immunobiology of herpes simplex virus (HSV) 
infection. The objectives of this work are to understand the mechanisms of herpesvirus-induced 
disease processes; to get insight into the mechanisms of protective immunity against infection, and 
to develop effective vaccines against HSV infection and disease. 
Dr. Bochsler will continue his research studies on the role of nitric oxide as a mediator of 
host defense in cattle. The goal of this study is further characterize nitric oxide generation by 
certain lung cells (bovine alveolar macrophages), to determine whether synthesis of nitric oxide is 
essential for killing of an important disease-producing organism of the respiratory tract of cattle, 
to investigate the effect of several bovine respiratory viruses on the ability of bovine alveolar 
macrophages to synthesize nitric oxide and to study the regulation of enzymes/factors responsible 
for synthesis of nitric oxide. 
Molecular Genetics 
Dr. Mendis-Handagama will use certain tumor cells (Leydig cell line) to address the 
basic questions on cholesterol transport mechanisms in the synthesis of hormones in the 
mammalian testis and also investigate hormonal production in aging and developing testes using 
the rat model. 
Dr. Wilkinson will investigate the molecular mechanisms of several human genetic 
diseases in mutant mIce. These include polycystic kidney disease, auto-immune disease and 
growth regulation. 
Dr. Sackman is studying methods for to improve adhesion of genetically-altered blood 
vessel cells to blood vessel grafts in her work on treatment of genetic vascular diseases. 
Dr. E. Schultze will work on a mutant mouse model of a specific type of anemia in 
people. He will characterize the molecular control of blood cell formation, iron metabolism and 
bone growth . 
Carcinogenesis 
Dr. Schuller will continue to determine the molecular mechanisms by which nicotine 
produces lung cancer and confirm whether drugs widely used for asthma and chronic bronchitis 
promote certain kinds of lung tumors in animal models. 
Dr. Hahn will identify, develop and evaluate new drugs that may augment standard anti­
cancer drugs by minimizing resistance of tumor cells to the latter drugs. He also will conduct 
clinical trials on client-owned pet animals with naturally-occurring cancer as models to identify 
new methods for the diagnosis and treatment of cancer. 
Dr. Merryman will work on new techniques to effectively evaluate the role of a certain 
growth factor {(TGF)-~} in the development of cancer (squamous cell carcinomas). 
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Expenditures 252 ,995 506,403 759,398 266,898 533,797 800,695 274,575 549,150 823,725 
Salaries 
Faculty 31 ,287 62,668 93,955 29,637 59,363 89,000 30,969 62,031 93,000 
Other Professional 50,555 101 ,262 151,817 35,118 70,343 105,461 37,296 74,704 112,000 
Clerical! Supporting 20,937 41 ,939 62,876 20,488 41 ,039 61,527 21 ,645 43,355 65,000 
Assistantships 10,027 20 ,081 30,108 19,927 39,915 59,842 20,446 40,954 61,400 























Travel 1,029 2,062 3,091 1,332 2,668 4,000 1,332 2,668 4,000 
Software 2,234 4,475 6,709 0 0 
Books &Journals 450 904 1,354 0 0 
Other Supplies 44,653 89 ,088 133,741 73,488 147,197 220,685 69,430 138,245 207,675 
Equipment 60,834 121 ,852 182,686 51 ,615 103,385 155,000 56,610 113,390 170,000 
Maintenance 4,772 9,560 14,332 6,901 16,415 23,316 8,741 17,509 26,250 
Scholarships 454 909 1,363 400 800 1,200 800 1,600 2,400 
Consultants 0 0 0 
Renovation 0 0 0 
Other (Specify) 0 0 0 
0 0 0 
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The University of Tennessee 

College of Veterinary Medicine 

Center of Excellence in Livestock Diseases and Human Health 

The Tennessee Higher Education Commission policies governing the Centers ofExcellence 
require that the centers be re-evaluated for continuation each five years after they are declared by 
the Commission as "Accomplished Centers." 
The Center was re-evaluated on February on February 9, 1996 and listed below is an excerpted 
report on the Center taken from THEC Five-Year Review submitted Mary 28, 1996. 
The center ofExcellence in Livestock Diseases and Human Health has a unique role in addressing 
the needs of animal agriculture in Tennessee and in providing a new dimension to human health 
research. The College of Veterinary Medicine has been a pioneer in the use of animal models to 
investigate several human diseases. It is unlikely that significant progress in understanding these 
diseases could have been made if these models had not been available. Center research focuses on 
the following specific five areas: inflammation and host defenses, growth factors and molecular 
genetics, infectious diseases and population medicine, in vitro toxicology and toxicokinetics, and 
carcinogenesis and developmental therapeutics. 
To address its mission, the Center has established the following goals: 
1. 	 To Improve the Quality ofHuman Life through Better Animal Health 
2. 	 To Augment Livestock Disease Research Capabilities in the Institute of Agriculture 
3. 	 To Identify and Characterize Animal Diseases that are Analogous to Human Health 
4. 	 To Study Animal Models for Better Understanding ofHuman Disease 
5. 	 To Understand the Pathogenesis and Characterize the Causative Agents ofCommonDiseases 
Important to the State of Tennessee 
6. 	 To Improve the Capabilities of the College of Veterinary Medicine, the College of 
Agricultural Sciences and Natural Resources, and the Agricultural Experiment Station to Deal 
with these Diseases 
7. 	 To Improve Facilities to Enable the College of Veterinary Medicine to Study More Effectively 
Infectious and Toxic Diseases of Animals 
8. 	 To Disseminate through the Extension Service Practical Information Required to Reduce the 
Incidence ofLivestock Diseases 
9. 	 To Develop New Strategies for the Prevention of Disease 
10. To Improve Facilities and Expertise in Order to Provide Improved Research Training 
11 . To Develop Innovative Approaches to the Treatment of Human Diseases 
One research project has focused on white blood cells, which are an important part of the immune 
system and contribute to host defense against infectious agents. This research has studied the role 
of white blood cells in mediation of host defense against infectious diseases of cattle. A better 
understanding of the bovine immune system is essential for understanding diseases in cattle and is 
important in designing strategies for prevention and treatment of infectious diseases in cattle. 
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Another research project (supported both by the National Institutes for Health and the Belgian 
pharmaceutical firm, SmithKline Beecham) is searching for successful vaccines against 
herpesvirus infection. 
Another project has the goal of improving reproductive efficiency in livestock by reducing 
stillbirths. 
Certain diseases in humans also affect animals and these animals can be used to model treatment 
in human subjects. One research project at the Center has focused on gene therapy for canine 
genetic enzyme deficiency, a model for the identical disease which occurs in human children. 
Another such project focuses in a mouse model of polycystic kidney disease, the most common 
inherited disease in humans and a major cause of disease and death. Using this mouse, Center 
researchers have been able to identify the first gene known to be associated with this costly and 
deadly disease. 
Bovine mastitis costs Tennessee producers of dairy products over $60 million annually, and tall 
fescue toxicosis in cattle costs Tennessee producers another $85 million annually. Center 
researchers have a model vaccine (developed with support from a large pharmaceutical firm) that 
may save Tennessee farmers millions of dollars every year. 
Another project has received nationwide attention: the first evidence that mothers who smoke 
during pregnancy may significantly increase the risk of cancer in their children. These findings 
may have a dramatic effect on prevention and treatment oflung cancer. 
The Center has been very successful in attracting external funding. Over the past five years, over 
$19 million has been awarded to the Center to support these research projects. While the College 
of Veterinary Medicine is among the smallest in the nation, it ranks fourth in external research 
funding . 
The Committee recommends to the governing board and the Commission that this Accomplished 
Center be continued. 
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Report of External Reylew T~am. March 25. 1996 
• OYERVIEW 
Since the last visit (October 1992), the Center has continued to make good progress. It's overall 
management is good and we were especially appreciative of the positive influence of Dr. Leon 
Potgieter, Assistant Director, who has clearly created a better focused, goal-oriented philosophy. 
This is good for the future of the Center, and should lead to even greater productivity. There has 
been some restructuring since the committee's visit in 1992. The new "focus groups" for the 
period 1996-2000 are different from those described in the 1990-95 report . These changes 
seem appropriate and reflect the willingness of the College to encourage the evolution and 
maturation of the Center. 
The internal peer review process for proposals submitted for funding by the Center is functioning 
especially well. Because of the potential risk that the Center may be seen as a "club" and might 
exclude some faculty who may have potential to make significant research contributions, 
competition for Center grants is now open to all faculty rather than a restricted group of 
participants in programs of the Center. The resources of the Center should fit well with the 
mission of the College and be of benefit to the whole faculty. 
We feel that the External Review Board will continue to playa useful role, especially in the political 
future of the Center. A four-member board (with two members rotating off periodically) seems 
appropriate. Visitation every three years provides a good interval for review. 
Extramural funding remains high; yet it has leveled off in recent years. This does not necessarily 
represent a concern in the currently unfavorable funding climate. Efforts of the Center to better 
define the focus group should enhance their competitiveness for extramural funding. 
The involvement of the new COE participants (resulting from faculty retirements) will stimulate the 
Center and further change its character, especially through recruitment of faculty who will 
enhance the CEO's goals . 
• PROGRAM REPORTS 
1 . Inflammation and host defenses 
This unit continues to fare well under good leadership. Here is a good example of the 
incorporation of new scientists who are changing the flavor of the COE. Dr. Rouse 
continues to be a major contributor who has garnered exceptional NIH support and plays a 
vital role in graduate education. The group's partnership with the Oakridge Laboratories is 
a major strength, and includes a recently funded NIH grant that will enhance graduate 
training opportunities for the College. 
2. Growth factors and molecular genetics 
The review team observes that this group, while continuing to be productive, seems to be 
less focused than may be desirable. There are many projects of differing character, 
headed in different directions. The review team is concerned about the future leadership 
of this unit and recommends that ways be found to restore focus and collaborative 
synergism to the group. Collaboration with Oakridge Laboratories in research involving 
transgenic animals will be a valuable focus for this group. 
3. Infectious diseases and population medicjne 
This is a good program which is producing excellent work. Nevertheless, the review team 
strongly urges the College leadership to encourage the development of the quantitative 
areas of population medicine and epidemiology. This aspect is all but absent from the 
group's current interests and may prove to be a negative political issue with agricultural 
groups and legislators. We understand that the epidemiologists among the college 
faculty are not participating in the COE. Perhaps there is an opportunity for the Dean to 
appoint an epidemiologist to the team, as the current peer review system for membership 
may fai l to fill this important need. 
4. In vjtro toxicology and toxjcokjnetjcs 
While this program remains an active and important part of the Center, it has suffered 
major losses of people and funds. Our impression of this unit is one of several good 
people going separate ways. The group should reexamine its goals and common 
interests. Great benefit would accrue from better connections with the State's diagnostic 
labs, medical schools, and the Oakridge Laboratory. 
5. Carcjnogenesis and developmental therapeutics 
This is a productive and innovative research enterprise that is unified behind a sovereign 
director. There is no question about the thematic focus of this unit. Nevertheless, the 
review team expresses concern for the growth of young scientists joining this group. 
Some attention might be given to the development of a more nurturing team-oriented 
environment for the good of the College: No doubt this group will continue to be highly 
productive. 
In conclusion, we congratulate the Dean and the faculty on the fine accomplishments of 
the Center. We are honored to serve as reviewers of its programs. The COE continues to 
be an important asset to the University and the State. Dr. Potgieter has provided an 
important influence on the Center's success. 
It will be helpful to review regularly the leadership, membership, and thematic focus of 
each research program in relatio n and goals of the COE and the College. 
Peter Eyre (Virginia Tech) 
Chair of Review Team 
John M. Bowen, University of Georgia 

Talmage T. Brown, North Carolina State University 

John A. Phillips, Vanderbilt University 
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